Health
Transforming how vaccines are made – BioPharma-Reporter.com
Synthetic biologists based at Northwestern University in the US have discovered a new way to increase production yields of protein-based vaccines five-fold, significantly…
In February, the researchers introduced a new biomanufacturing platform – called in vitro conjugate vaccine expression (iVAX) that they had developed. That platform is designed, they said, to quickly make shelf-stable vaccines at the point of care, ensuring they will not go to waste due to errors in transportation or storage.
In a new study, published in Nature Communications today
-
General19 hours agoWondering about winter | The Spectator Australia
-
Noosa News18 hours agoJane Bunn weather: Cyclone Errol forms as effects of Alfred still felt across Queensland
-
Business23 hours agoAre Domain Holdings shares undervalued?
-
Business21 hours agoWiseTech shares lift off amid agreement with founder Richard White